An analysis of the costs and treatment success of collaborative arrangements among public and private providers for tuberculosis control in Indonesia

Health Policy

Volumn 93, Issue 2-3, 2009, Pages 214-224

  Johns, Benjamin ^a   Probandari, Ari ^b,c,d   Mahendradhata, Yodi ^b,e   Ahmad, Riris Andono ^b,f  

^a Gadjah Mada University ^*  (United States)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c SEBELAS MARET UNIVERSITY   (Indonesia)

^d UMEÅ UNIVERSITY   (Sweden)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cost effectiveness; Indonesia; Public private mix; Tuberculosis

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; INDONESIA; LUNG TUBERCULOSIS; OUTPATIENT CARE; PATIENT REFERRAL; PRIVATE PRACTICE; PUBLIC HEALTH SERVICE; SHORT COURSE THERAPY; SPUTUM SMEAR; TREATMENT OUTCOME; TUBERCULOSIS CONTROL;

COOPERATIVE BEHAVIOR; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; HEALTH FACILITIES; HUMANS; INDONESIA; INTERVIEWS AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); PUBLIC-PRIVATE SECTOR PARTNERSHIPS; REFERRAL AND CONSULTATION; TUBERCULOSIS;

EID: 70449091821     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2009.08.004     Document Type: Article

References (39)

1. WHO. The stop TB strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals (2006), WHO, Geneva, Switzerland
2. Borghi J., Gorter A., Sandiford P., and Segura Z. The cost-effectiveness of a competitive voucher scheme to reduce sexually transmitted infections in high-risk groups in Nicaragua. Health Policy and Planning 20 July (4) (2005) 222-231
3. Goodman C.A., Mutemi W.M., Baya E.K., Willetts A., and Marsh V. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya. Health Policy and Planning 21 July (4) (2006) 275-288
4. Schwartz J.B., and Bhushan I. Improving immunization equity through a public-private partnership in Cambodia. Bulletin of the World Health Organization 82 September (9) (2004) 661-667
5. Sinanovic E., and Kumaranayake L. Quality of tuberculosis care provided in different models of public-private partnerships in South Africa. The International Journal of Tuberculosis and Lung Disease 10 July (7) (2006) 795-801
6. Sinanovic E., and Kumaranayake L. Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa. Cost Effectiveness and Resource Allocation 4 (2006) 11
7. Lonnroth K., Aung T., Maung W., Kluge H., and Uplekar M. Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection. Health Policy and Planning 22 May (3) (2007) 156-166
8. Ferroussier O., Kumar M.K., Dewan P.K., et al. Cost and cost-effectiveness of a public-private mix project in Kannur District, Kerala, India, 2001-2002. The International Journal of Tuberculosis and Lung Disease 11 July (7) (2007) 755-761
9. Chakaya J., Uplekar M., Mansoer J., et al. Public-private mix for control of tuberculosis and TB-HIV in Nairobi, Kenya: outcomes, opportunities and obstacles. The International Journal of Tuberculosis and Lung Disease 12 November (11) (2008) 1274-1278
10. Floyd K., Arora V.K., Murthy K.J., et al. Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India. Bulletin of the World Health Organization 84 June (6) (2006) 437-445
11. Quy H.T., Lonnroth K., Lan N.T., and Buu T.N. Treatment results among tuberculosis patients treated by private lung specialists involved in a public-private mix project in Vietnam. The International Journal of Tuberculosis and Lung Disease 7 December (12) (2003) 1139-1146
12. Quy H.T., Lan N.T., Lonnroth K., Buu T.N., Dieu T.T., and Hai L.T. Public-private mix for improved TB control in Ho Chi Minh City, Vietnam: an assessment of its impact on case detection. The International Journal of Tuberculosis and Lung Disease 7 May (5) (2003) 464-471
13. Dewan P.K., Lal S.S., Lonnroth K., et al. Improving tuberculosis control through public-private collaboration in India: literature review. British Medical Journal 332 March (7541) (2006) 574-578
14. Lonnroth K., Uplekar M., Arora V.K., et al. Public-private mix for DOTS implementation: what makes it work?. Bulletin of the World Health Organization 82 August (8) (2004) 580-586
15. Mahendradhata Y., Lambert M.L., Boelaert M., and Van der S.P. Engaging the private sector for tuberculosis control: much advocacy on a meagre evidence base. Tropical Medicine International Health 12 March (3) (2007) 315-316
16. Karki D.K., Mirzoev T.N., Green A.T., Newell J.N., and Baral S.C. Costs of a successful public-private partnership for TB control in an urban setting in Nepal. BMC Public Health 7 (2007) 84
17. WHO. Global tuberculosis control: surveillance, planning and financing. WHO report 2008. Geneva, Switzerland: WHO; 2008.
18. Ministry of Health Indonesia. Indonesia health profile 2003: towards a healthy Indonesia (2005), Ministry of Health, Jakarta, Indonesia
19. NIHRD. The tuberculosis prevalence survey in Indonesia 2004 (2008), Ministry of Health, Jakarta, Indonesia
20. Ministry of Health Indonesia. Framework for the strategic plan for TB control in Indonesia: 2006-2010 (2006), Ministry of Health, Jakarta, Indonesia
21. Irawati S.R., Basri C., Arias M.S., et al. Hospital DOTS linkage in Indonesia: a model for DOTS expansion into government and private hospitals. The International Journal of Tuberculosis and Lung Disease 11 January (1) (2007) 33-39
22. Mahendradhata Y., Utarini A., Lazuardi U., Boelaert M., and Stuyft P.V. Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential. Tropical Medicine & International Health 12 October (10) (2007) 1218-1224
23. Departmen Kesehatan Republik Indonesia. Pedoman Nasional: Penenggulangan Tuberkulosis, Edisi 2. Jakarta, Indonesia, Gerdunas TB, 2007.
24. NTP MOH Indonesia. Cost of TB Drugs; 2006. Ref Type, Verbal Communication.
25. Stata Corp. Stata statistical software: Release 10. College Station, TX, State Corporation; 2007. Ref Type, Data File.
26. Briggs A.H., Wonderling D.E., and Mooney C.Z. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Economics 6 July (4) (1997) 327-340
27. Microsoft Corporation. Redmond, WA: Excel, Inc.; 2003. Ref Type, Data File.
28. Stata Corp. Base reference manual: Release 10. College Station, TX: Stata Corporation; 2007.
29. Duan N. Smearing estimate: a nonparametric retransformation method. Journal of the American Statistical Association 78 (1983) 605-610
30. Palisade Corporation. Newfield, NY: @Risk version 4; 2000. Ref Type: Data File.
31. Schmidt P., and Lin T. Simple tests of alternative specifications in stochastic frontier models. Journal of Econometrics 24 (1984) 349-361
32. Lonnroth K., Thuong L.M., Lambregts K., Quy H.T., and Diwan V.K. Private tuberculosis care provision associated with poor treatment outcome: comparative study of a semi-private lung clinic and the NTP in two urban districts in Ho Chi Minh City, Vietnam. National Tuberculosis Programme. The International Journal of Tuberculosis and Lung Disease 7 February (2) (2003) 165-171
33. Uplekar M., Juvekar S., Morankar S., Rangan S., and Nunn P. Tuberculosis patients and practitioners in private clinics in India. The International Journal of Tuberculosis and Lung Disease 2 April (4) (1998) 324-329
34. Floyd K. Cost and cost-effectiveness of PPM-DOTS: Evidence to date. 2007. Cape Town, South Africa, IUATLD conference; 11-10-2007. Ref Type: Presentation.
35. Soewondo P, Nadjib M, Soeharno N, Dadun, Sucahya P, Darmawan E. Health financing analysis of the TB programs in 7 districts of 4 provinces in Indonesia 2006; 2006. Ref Type: Unpublished Work.
36. Drummond M., Sculpher M., Torrance G., O'Brien B., and Stoddart G. Methods for the economic evaluation of health care programmes. 3rd ed. (2005), Oxford University Press, Oxford, UK
37. Gold M., Siegel J., Russell L., and Weinstein Me. Cost-effectiveness in health and medicine (1996), Oxford University Press, Oxford, UK
38. Edejar T., Baltussen R., Adam T., et al. Making choices in health: WHO guide to cost-effectiveness (2003), WHO, Geneva, Switzerland
39. Berwick D.M. The science of improvement. The Journal of the American Medical Association 299 March (10) (2008) 1182-1184